Regulation of thyroid hormone receptor isoforms in physiological and pathological cardiac hypertrophy

K Kinugawa1, K Yonekura, R C Ribeiro

  • 1Division of Cardiology, University of Colorado Health Sciences Center, Denver, CO, USA.

Circulation Research
|September 29, 2001
PubMed

Insights

Thyroid hormone receptors (TRs) in heart cells change with cardiac hypertrophy. TR levels are altered, explaining molecular changes in both physiological and pathological heart enlargement.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Endocrinology

Background:

  • Cardiac hypertrophy involves altered gene expression of thyroid hormone (TH)-responsive genes like alpha- and beta-myosin heavy chain (MyHC) and SERCA.
  • TH treatment can reverse pathological hypertrophy, suggesting a role for TH signaling, yet serum TH levels are often normal.

Purpose of the Study:

  • To investigate the regulation and distinct functions of thyroid hormone receptor (TR) subtypes (TRbeta1, TRalpha1, TRalpha2) in rat cardiac hypertrophy models.
  • To determine if changes in myocyte TR levels contribute to the molecular phenotypes observed in physiological and pathological cardiac hypertrophy.

Main Methods:

  • Studied TR subtype expression in rat cardiac hypertrophy models induced by phenylephrine (in culture) and pressure overload (in vivo).
  • Examined TR expression in models mimicking hypothyroid-like and hyperthyroid-like states.
  • Utilized myocyte culture experiments with TR overexpression, triiodothyronine (T3) treatment, and TR isoform-selective agonists (GC-1) to assess functional coupling.

Main Results:

  • All three TR subtypes were downregulated in hypertrophy models with a hypothyroid-like mRNA phenotype (phenylephrine, pressure overload).
  • Myocyte TRbeta1 was upregulated in models with a hyperthyroid-like phenotype (T3, exercise).
  • TRbeta1 was linked to beta-MyHC, SERCA, and TRbeta1 transcription, while TRalpha1 influenced alpha-MyHC transcription and myocyte size.

Conclusions:

  • Thyroid hormone receptor isoforms (TRbeta1, TRalpha1) exhibit distinct regulation and functional roles in rat cardiac myocytes.
  • Altered expression of myocyte TRs contributes to the molecular characteristics of physiological and pathological cardiac hypertrophy.

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...